Affiliation:
1. Klinik Bavaria
2. Rostock University Medical Center
3. Joint Practice Neurology and Psychiatry Geislingen
4. Technical University Dresden
Abstract
Abstract
Opsoclonus myoclonus syndrome (OMS) is a rare neurological encephalopathic entity associated with non-specific infections or cancer processes that has been occasionally described in the setting of SARS-CoV-2 infection. We report a case of a 53-year-old man with SARS-CoV-2 infection, who developed clinical features of opsoclonus-myoclonus syndrome. Of particular note, cerebrospinal fluid analysis (CSF) analysis revealed the production of myelin oligodendrocyte glycoprotein (MOG) antibodies, suggesting an underlying neuroimmunological mechanism associated with infection with the novel SARS-CoV-2 virus.
Publisher
Research Square Platform LLC
Reference32 articles.
1. Opsoclonus myoclonus syndrome in a postpartum period;Adhikari S;Mult Scler Relat Disord,2021
2. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies;Armangué T;JAMA Neurol,2016
3. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease;Balcom EF;Brain,2021
4. Banks SA, Morris PP, Chen JJ, Pittock SJ, et al. (2020) Brainstem and cerebellar involvement in MOG-IgG-associated disorder cersus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. doi.10.1136/jnnp-2020-325121
5. Autoantigen diversity in the opsoclonus–myoclonus syndrome;Bataller L;Ann Neurol,2003